Lantheus names Bailey new president/CEO

Diagnostic imaging agent developer Lantheus Medical Imaging has named Jeffrey Bailey as the company's new president and CEO.

Lantheus also announced that Brian Markison, who joined the company's board of directors in September 2012, has been appointed as chairman.

Bailey replaces Donald Kiepert, who resigned from Lantheus to pursue other opportunities, the firm said. Bailey most recently served as chief operating officer for Fougera Pharmaceuticals, where he led the company's generic and branded pharmaceuticals products, including overseeing sales, marketing, manufacturing, regulatory, quality, R&D, supply chain, and operations.

Prior to joining Fougera in August 2011, Bailey served as the chief commercial officer of King-Pfizer Pharmaceuticals.

Page 1 of 436
Next Page